Unique molecular signatures influencing the biological function and fate of post-natal stem cells isolated from different sources
Authors:
- 10 December 2012
- journal article
- clinical trial
- Published by Hindawi Limited in Journal of Tissue Engineering and Regenerative Medicine
- Vol. 9 (12) , E252-E266
Abstract
The discovery of mesenchymal stem cells (MSCs) from a myriad of tissues has triggered the initiative of establishing tailor‐made stem cells for disease‐specific therapy. Nevertheless, lack of understanding on the inherent differential propensities of these cells may restrict their clinical outcome. Therefore, a comprehensive study was done to compare the proliferation, differentiation, expression of cell surface markers and gene profiling of stem cells isolated from different sources, viz. bone marrow, Wharton's jelly, adipose tissue and dental pulp. We found that although all MSCs were phenotypically similar to each other, Wharton's jelly (WJ) MSCs and dental pulp stem cells (DPSCs) were highly proliferative as compared to bone marrow (BM) MSCs and adipose tissue (AD) MSCs. Moreover, indistinguishable cell surface characteristics and differentiation capacity were confirmed to be similar among all cell types. Based on gene expression profiling, we postulate that BM‐MSCs constitutively expressed genes related to inflammation and immunodulation, whereas genes implicated in tissue development were highly expressed in AD‐MSCs. Furthermore, the transcriptome profiling of WJ‐MSCs and DPSCs revealed an inherent bias towards the neuro‐ectoderm lineage. Based on our findings, we believe that there is no unique master mesenchymal stem cell that is appropriate to treat all target diseases. More precisely, MSCs from different sources exhibit distinct and unique gene expression signatures that make them competent to give rise to specific lineages rather than others. Therefore, stem cells should be subjected to rigorous characterization and utmost vigilance needs to be adopted in order to choose the best cellular source for a particular disease. Copyright © 2012 John Wiley & Sons, Ltd.Keywords
This publication has 69 references indexed in Scilit:
- Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applicationsStem Cell Research, 2010
- Emerging roles of microRNAs in the control of embryonic stem cells and the generation of induced pluripotent stem cellsDevelopmental Biology, 2010
- Characterization of stem and progenitor cells in the dental pulp of erupted and unerupted murine molarsBone, 2010
- Human Bone Marrow Mesenchymal Stem Cells: A Systematic Reappraisal Via the Genostem ExperienceStem Cell Reviews and Reports, 2010
- Characterization of mesenchymal stem cells from human vocal fold fibroblastsThe Laryngoscope, 2010
- Representing ontogeny through ontology: A developmental biologist's guide to the gene ontologyMolecular Reproduction and Development, 2009
- Gene Expression Profile of Mesenchymal Stem Cells from Paired Umbilical Cord Units: Cord is Different from BloodStem Cell Reviews and Reports, 2009
- Sox2 and Oct‐3/4: a versatile pair of master regulators that orchestrate the self‐renewal and pluripotency of embryonic stem cellsWIREs Mechanisms of Disease, 2009
- Endothelial differentiation of Wharton's jelly–derived mesenchymal stem cells in comparison with bone marrow–derived mesenchymal stem cellsExperimental Hematology, 2009
- Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cellsJournal of Tissue Engineering and Regenerative Medicine, 2009